Our Brands

SYSMEX
Lighting the way with diagnostics

Sysmex Corporation have over 50 years global actively set new standards and driven innovation designing and producing diagnostic solutions for medical laboratories, including automation. 
Sysmex is one of the world’s largest manufacturers of blood coagulation analyzer and total hemostasis solution provider for laboratories of all sizes around the world.  With Sysmex Hemostasis Systems, labs can accurately and precisely measure the factors required to stop bleeding and identify possible abnormalities that could lead to excessive bleeding or thrombosis.
The CA, CS and CN coagulation analyzer functions including clotting, chromogenic, latex agglutination immunoassay, and platelet aggregation. The analyzers range is from semi-automated coagulation analyzers to fully automated coagulation analyzers up to 450 tests/h throughput. the chemiluminescent enzyme immunoassay (CLEIA) function on CN-3500 and CN-6500 is available.

https://www.sysmex-europe.com/products/diagnostics/haemostasis.html#tx-products

 

SIEMENS
Healthineers

Siemens Healthineers offers a broad portfolio of innovative hemostasis solutions that fit like they were made just for your lab. powers up your lab with a comprehensive portfolio of hemostasis products. The wide range of analyzers and assays is perfectly aligned to improve operational efficiency in the laboratory. Our strong partnership with Sysmex® Corporation enables us to deliver complete solutions for your routine or specialty testing needs. 

https://www.siemens-healthineers.com/hemostasis/innovance-assays

HYPHEN
BioMed

HYPHEN BioMed is designing, developing, manufacturing and marketing in-vitro research and diagnostic immunological, clotting and chromogenic methods reagents for the exploration of Thrombosis, Hemostasis and Auto-Immunity. In addition to medical laboratories centers, our over 300 products reagents are recognized as useful tools for the pharmaceutical research and drug discovery, and allow testing the efficacy and safety of new anticoagulant and cardio-vascular drugs under current development. When needed, technologies are then available as companion diagnostics for new drugs.

  • HEMOCLOT™: A range of routine and specialized clotting assays designed with highly purified coagulation factors and other raw materials.
  • BIOPHEN™: Innovative technology of chromogenic assays as well as calibrators and controls (traceable to the WHO International Standards) fully automatable on laboratory instruments.
  • ZYMUPHEN™: Proprietary bio-immunoassays, highly specific, for testing rare protein activities in coagulation and fibrinolysis (such as tPA, PAI-1, TF, TAFI, EVs…)
  • ZYMUTEST™: Complete line of highly sensitive, accurate and specific Enzyme Immunoassays (ELISA) which remains the reference method for the exploration of biomarkers and proteins of thrombotic diseases, fibrinolysis or autoimmunity and drug induced thrombocytopenia for example.
  • LIAPHEN™: A range of enhanced turbidimetric latex immunoassays for quantitative determination of various hemostasis proteins and biomarkers on citrated plasma, fully automatable on laboratory instruments.

www.hyphen-biomed.com